BetterScholar BetterScholar

C. Berra

Pharmacological Research, Cellular and Molecular Life Sciences, Diabetes Technology & Therapeutics, Drug Target Insights, Acta Diabetologica
9
Role
Title
Level Year L/R
🐜 The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists.
16 auth. G. Bendotti, L. Montefusco, M. E. Lunati, V. Usuelli, I. Pastore, Elisa Lazzaroni, E. Assi, A. Seelam, Basset El Essawy, Y. Jang, ... C. Loretelli, F. D’Addio, C. Berra, M. Ben Nasr, G. Zuccotti, P. Fiorina 		7 2022
7
🐜
🐜 Anti-diabetic drugs and weight loss in patients with type 2 diabetes.
15 auth. Elisa Lazzaroni, M. Ben Nasr, C. Loretelli, I. Pastore, L. Plebani, M. E. Lunati, Luciana Vallone, A. Bolla, A. Rossi, L. Montefusco, ... Elio Ippolito, C. Berra, F. D’Addio, G. Zuccotti, P. Fiorina 		6 2021
6
🐜
🐜 Anti-inflammatory effect of SGLT-2 inhibitors via uric acid and insulin
13 auth. Rosalba La Grotta, P. de Candia, F. Olivieri, G. Matacchione, A. Giuliani, M. R. Rippo, E. Tagliabue, M. Mancino, Francesca Rispoli, Sabina Ferroni, ... C. Berra, A. Ceriello, F. Prattichizzo 		6 2022
6
🐜
🐜 Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
8 auth. F. Bifari, R. Manfrini, M. Dei Cas, C. Berra, M. Siano, M. Zuin, ... R. Paroni, F. Folli 		5 2018
5
🐜
🐜 Inter-day glycemic variability assessed by continuous glucose monitoring in insulin-treated type 2 diabetes patients on hemodialysis.
8 auth. M. Mirani, C. Berra, S. Finazzi, A. Calvetta, M. Radaelli, F. Favareto, ... G. Graziani, S. Badalamenti 		5 2010
5
🐜
🐜 SGLT2-inhibitors are Effective and Safe in the Elderly: the SOLD Study.
22 auth. M. E. Lunati, Vincenzo Cimino, Alessandra Gandolfi, Matteo Trevisan, L. Montefusco, I. Pastore, Camilla Pace, N. Betella, G. Favacchio, M. Bulgheroni, ... L. Bucciarelli, Giulia Massari, Cristina Mascardi, A. Girelli, P. Morpurgo, F. Folli, L. Luzi, M. Mirani, B. Pintaudi, F. Bertuzzi, C. Berra, P. Fiorina 		5 2022
5
🐜
🦁 Blood pressure control in type 2 diabetes mellitus with arterial hypertension. The important ancillary role of sglt2-inhibitors and glp1-receptor agonists.
9 auth. C. Berra, R. Manfrini, D. Regazzoli, M. Radaelli, O. Disoteo, C. Sommese, ... P. Fiorina, G. Ambrosio, F. Folli 		5 2020
5
🦁
🐬 The role of patient preferences in adherence to treatment in chronic disease: a narrative review
S. Losi, C. Berra, R. Fornengo, D. Pitocco, G. Biricolti, M. Federici 		5 2021
5
🐬
🦁 Hypoglycemia and hyperglycemia are risk factors for falls in the hospital population
10 auth. C. Berra, F. Fazio, E. Azzolini, M. Albini, F. Zangrandi, M. Mirani, ... S. Garbossa, R. Guardado-Mendoza, G. Condorelli, F. Folli 		4 2019
4
🦁